<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>CEO &amp; co-founder of Infinimmune (https://Infinimmune.com) — antibodies, biologics, genomics, &amp; whatever else</description><link>https://bsky.app/profile/wjm.bsky.social</link><title>@wjm.bsky.social - Wyatt McDonnell</title><item><link>https://bsky.app/profile/wjm.bsky.social/post/3kgvto4ofwx2r</link><description>Excited to announce a new discovery collaboration between Infinimmune and Grid Therapeutics. We’ll be identifying novel antibody therapeutics from cancer patients with exceptional outcomes and look forward to sharing our findings in the future. &#xA;&#xA;https://www.businesswire.com/news/home/20231219029783/en/Infinimmune-Announces-Partnership-with-Grid-Therapeutics-to-Conduct-Deep-Sequencing-of-B-Cells-for-Oncology-Drug-Discovery</description><pubDate>19 Dec 2023 15:20 +0000</pubDate><guid isPermaLink="false">at://did:plc:eeguaxtlhjpkkjmuezsvcohk/app.bsky.feed.post/3kgvto4ofwx2r</guid></item></channel></rss>